Dialysate Concentrates Used in Hemodialysis: Safety Communication – Alkali Dosing Errors

by FDA on May 25, 2012

in MedWatch

Risk of elevated bicarbonate levels in patients undergoing hemodialysis, which can contribute to metabolic alkalosis, a significant risk factor associated with cardiopulmonary arrest, low blood pressure, hypokalemia, hypoxemia, hypercapnia, and cardiac arrhythmia.

This is a summary of an alert issued by MedWatch: The FDA Safety Information and Adverse Event Reporting Program. The link below will take you to the original notice.

View Full Details Of The Original MedWatch Notice Here.

Bookmark and Share

Leave a Comment

Previous post:

Next post: